Xenofontos, Eleni
Renieris, Georgios
Kalogridi, Maria
Droggiti, Dionyssia-Eirini
Synodinou, Kalliopi
Damoraki, Georgia
Koufargyris, Panagiotis
Sabracos, Labros
Giamarellos-Bourboulis, Evangelos J.
Funding for this research was provided by:
Hellenic Institute for the Study of Sepsis
Horizon 2020 Framework Programme (676129)
Article History
Received: 22 September 2021
Accepted: 14 February 2022
First Online: 8 March 2022
Competing interests
: E.J. Giamarellos-Bourboulis has received honoraria from Abbott CH, bioMérieux, Brahms GmbH, GSK, InflaRx GmbH, Sobi and XBiotech Inc; independent educational grants from Abbott CH, AxisShield, bioMérieux Inc, InflaRx GmbH, Johnson & Johnson, MSD, Sobi and XBiotech Inc.; and funding from the Horizon2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and the Horizon 2020 European Grants ImmunoSep and RISCinCOVID (granted to the Hellenic Institute for the Study of Sepsis)<b>.</b> Georgios Renieris is funded by the European Union's Horizon 2020 Marie Skłodowska-Curie grant European Sepsis Academy N<sup>o</sup> 676129. The other authors do not have any competing interest to declare.